US Patent Issued to The Board of Trustees of the Leland Stanford Junior University on Oct. 20 for "Generation of induced human thymic epithelial cells and its application in cell-based immunotherapies" (California Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,767,929, issued on Oct. 20, was assigned to The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Generation of induced human thymic epithelial cells and its application in cell-based immunotherapies" was invented by Katja G. Weinacht (Stanford, Calif.) and Hui Gai (Stanford, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of differentiating pluripotent stem cells into thymic epithelial progenitor cells are provided."

The patent was filed on Jan. 13, 2022, under Application No. 18/261,471.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?S...